ABT vs ASIC · P/E 25, rev $44.33B vs rev $424.3M
Abbott Laboratories (ABT) versus Ategrity Specialty Holdings LLC (ASIC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Ategrity Specialty Holdings LLC (ASIC) is a insurance - property & casualty company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ASIC revenue for 2025-12-31 was $424.3M. Net income was $74.0M. Revenue was up 23.4% from 2024-12-31 to 2025-12-31. ASIC currently screens at market cap $0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ASIC currently screens at market cap $0.
Not investment advice. Open the ABT and ASIC stock pages for the full models.
Not investment advice.